https://yl919inhibitor.com/era....-involving-cry11-ver
This research investigated the encapsulation of CpG-modified oligodeoxynucleotides (CpG-ODNs) and the recombinant influenza M2 protein ectodomain inside N-trimethyl chitosan (TMC) nanoparticles. After producing TMC nanoparticles, we examined their morphological characteristics, loading efficiency, in vitro antigen release rate, and capacity for inducing immune responses against M2e in intranasally inoculated mice. The size and zeta potential data obtained in this study
כמו
תגובה
לַחֲלוֹק
